SAM-e S-adenosyl methionine
Selected indexed studies
- Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. (Nature, 2019) [PMID:31043742]
- Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder. (J Clin Psychiatry, 2009) [PMID:19909689]
- Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts. (Nat Biotechnol, 2019) [PMID:30962542]
_Worker-drafted node — pending editorial review._
Connections
SAM-e S-adenosyl methionine helps
Sources
- S-Adenosylmethionine. (2000) pubmed
- Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder. (2009) pubmed
- Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. (2019) pubmed
- Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts. (2019) pubmed
- The functional roles of S-adenosyl-methionine and S-adenosyl-homocysteine and their involvement in trisomy 21. (2024) pubmed
- Serine metabolism antagonizes antiviral innate immunity by preventing ATP6V0d2-mediated YAP lysosomal degradation. (2021) pubmed
- SIP: A computational prediction of S-Adenosyl methionine (SAM) interacting proteins and their interaction sites through primary structures. (2022) pubmed
- S-Adenosyl Methionine in the Therapy of Depression and Other Psychiatric Disorders. (2016) pubmed
- Targeting the methionine-methionine adenosyl transferase 2A- S -adenosyl methionine axis for cancer therapy. (2022) pubmed
- Metabolism and epigenetics. (2015) pubmed